Thailand · Delayed Price · Currency is THB BKK:KLINIQ Statistics
Total Valuation
BKK:KLINIQ has a market cap or net worth of THB 7.21 billion. The enterprise value is 7.05 billion.
| Market Cap | 7.21B |
| Enterprise Value | 7.05B |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | Aug 27, 2026 |
Share Statistics
BKK:KLINIQ has 220.00 million shares outstanding.
| Current Share Class | 220.00M |
| Shares Outstanding | 220.00M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 65.89% |
| Owned by Institutions (%) | 0.76% |
| Float | 75.05M |
Valuation Ratios
The trailing PE ratio is 17.06 and the forward PE ratio is 13.66. BKK:KLINIQ's PEG ratio is 0.63.
| PE Ratio | 17.06 |
| Forward PE | 13.66 |
| PS Ratio | 1.76 |
| PB Ratio | 3.90 |
| P/TBV Ratio | 3.92 |
| P/FCF Ratio | 15.18 |
| P/OCF Ratio | 9.62 |
| PEG Ratio | 0.63 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.34, with an EV/FCF ratio of 14.85.
| EV / Earnings | 16.69 |
| EV / Sales | 1.72 |
| EV / EBITDA | 8.34 |
| EV / EBIT | 12.62 |
| EV / FCF | 14.85 |
Financial Position
The company has a current ratio of 1.23, with a Debt / Equity ratio of 0.35.
| Current Ratio | 1.23 |
| Quick Ratio | 0.74 |
| Debt / Equity | 0.35 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 1.36 |
| Interest Coverage | 20.51 |
Financial Efficiency
Return on equity (ROE) is 23.51% and return on invested capital (ROIC) is 26.45%.
| Return on Equity (ROE) | 23.51% |
| Return on Assets (ROA) | 10.51% |
| Return on Invested Capital (ROIC) | 26.45% |
| Return on Capital Employed (ROCE) | 23.86% |
| Weighted Average Cost of Capital (WACC) | 5.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 1.24 |
| Inventory Turnover | 5.70 |
Taxes
In the past 12 months, BKK:KLINIQ has paid 115.89 million in taxes.
| Income Tax | 115.89M |
| Effective Tax Rate | 21.51% |
Stock Price Statistics
The stock price has increased by +24.76% in the last 52 weeks. The beta is 0.36, so BKK:KLINIQ's price volatility has been lower than the market average.
| Beta (5Y) | 0.36 |
| 52-Week Price Change | +24.76% |
| 50-Day Moving Average | 29.17 |
| 200-Day Moving Average | 26.11 |
| Relative Strength Index (RSI) | 75.34 |
| Average Volume (20 Days) | 414,739 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:KLINIQ had revenue of THB 4.10 billion and earned 422.30 million in profits. Earnings per share was 1.92.
| Revenue | 4.10B |
| Gross Profit | 2.09B |
| Operating Income | 558.46M |
| Pretax Income | 538.65M |
| Net Income | 422.30M |
| EBITDA | 689.85M |
| EBIT | 558.46M |
| Earnings Per Share (EPS) | 1.92 |
Balance Sheet
The company has 811.45 million in cash and 646.79 million in debt, with a net cash position of 164.66 million or 0.75 per share.
| Cash & Cash Equivalents | 811.45M |
| Total Debt | 646.79M |
| Net Cash | 164.66M |
| Net Cash Per Share | 0.75 |
| Equity (Book Value) | 1.85B |
| Book Value Per Share | 8.37 |
| Working Capital | 257.52M |
Cash Flow
In the last 12 months, operating cash flow was 748.96 million and capital expenditures -274.24 million, giving a free cash flow of 474.72 million.
| Operating Cash Flow | 748.96M |
| Capital Expenditures | -274.24M |
| Depreciation & Amortization | 131.39M |
| Net Borrowing | -151.37M |
| Free Cash Flow | 474.72M |
| FCF Per Share | 2.16 |
Margins
Gross margin is 50.88%, with operating and profit margins of 13.61% and 10.29%.
| Gross Margin | 50.88% |
| Operating Margin | 13.61% |
| Pretax Margin | 13.12% |
| Profit Margin | 10.29% |
| EBITDA Margin | 16.81% |
| EBIT Margin | 13.61% |
| FCF Margin | 11.57% |
Dividends & Yields
This stock pays an annual dividend of 1.45, which amounts to a dividend yield of 4.43%.
| Dividend Per Share | 1.45 |
| Dividend Yield | 4.43% |
| Dividend Growth (YoY) | 12.41% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 75.54% |
| FCF Payout Ratio | 75.54% |
| Buyback Yield | n/a |
| Shareholder Yield | 4.43% |
| Earnings Yield | 5.86% |
| FCF Yield | 6.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for BKK:KLINIQ is 37.19, which is 13.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 37.19 |
| Price Target Difference | 13.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.06% |
| EPS Growth Forecast (3Y) | 18.71% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:KLINIQ has an Altman Z-Score of 3.97 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.97 |
| Piotroski F-Score | 5 |